Swiss drugmaker Roche to invest $50bn in US manufacturing amid tariff fears
Company says it will create more than 12,000 new jobs as pharmaceutical industry braces for Trump leviesThe Swiss drugmaker Roche has announced it will put $50bn (£37bn) into manufacturing in the US over the next five years, joining the queue of companies unveiling investments to try to head off potentially punitive Donald Trump tariffs.The pharmaceutical multinational said on Tuesday that the investment would create more than 12,000 new jobs, including 6,500 in construction and 1,000 at new and expanded existing facilities in the US, including factories and distribution centres in Kentucky, New Jersey and California. Continue reading...

Company says it will create more than 12,000 new jobs as pharmaceutical industry braces for Trump levies
The Swiss drugmaker Roche has announced it will put $50bn (£37bn) into manufacturing in the US over the next five years, joining the queue of companies unveiling investments to try to head off potentially punitive Donald Trump tariffs.
The pharmaceutical multinational said on Tuesday that the investment would create more than 12,000 new jobs, including 6,500 in construction and 1,000 at new and expanded existing facilities in the US, including factories and distribution centres in Kentucky, New Jersey and California. Continue reading...